These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2113607)

  • 1. Mitomycin antibiotic reductive potential and related pharmacological activities.
    Pan SS; Gonzalez H
    Mol Pharmacol; 1990 Jun; 37(6):966-70. PubMed ID: 2113607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.
    Pritsos CA; Sartorelli AC
    Cancer Res; 1986 Jul; 46(7):3528-32. PubMed ID: 3011250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
    Lee JH; Naito M; Tsuruo T
    Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the superoxide dismutase inhibitor, diethyldithiocarbamate, on the cytotoxicity of mitomycin antibiotics.
    Pritsos CA; Keyes SR; Sartorelli AC
    Cancer Biochem Biophys; 1989 Oct; 10(4):289-98. PubMed ID: 2559790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase.
    Hodnick WF; Sartorelli AC
    Cancer Res; 1993 Oct; 53(20):4907-12. PubMed ID: 8402680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.
    Yu F; Pan SS
    Mol Pharmacol; 1993 Jun; 43(6):863-9. PubMed ID: 8391116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mitomycin C by NADPH:cytochrome P-450 reductase.
    Bligh HF; Bartoszek A; Robson CN; Hickson ID; Kasper CB; Beggs JD; Wolf CR
    Cancer Res; 1990 Dec; 50(24):7789-92. PubMed ID: 2123741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C.
    Suresh Kumar G; Lipman R; Cummings J; Tomasz M
    Biochemistry; 1997 Nov; 36(46):14128-36. PubMed ID: 9369485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
    Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
    Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS; Yu F; Hipsher C
    Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lucigenin as a substrate of microsomal NAD(P)H-oxidoreductases.
    Schepetkin IA
    Biochemistry (Mosc); 1999 Jan; 64(1):25-32. PubMed ID: 9986909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase.
    Yee SB; Pritsos CA
    Arch Biochem Biophys; 1997 Nov; 347(2):235-41. PubMed ID: 9367530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C.
    Keyes SR; Heimbrook DC; Fracasso PM; Rockwell S; Sligar SG; Sartorelli AC
    Adv Enzyme Regul; 1985; 23():291-307. PubMed ID: 3934922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA alkylation by enzyme-activated mitomycin C.
    Pan SS; Iracki T; Bachur NR
    Mol Pharmacol; 1986 Jun; 29(6):622-8. PubMed ID: 3086708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells.
    Lee CS; Park SY; Ko HH; Han ES
    Biochem Pharmacol; 2004 Nov; 68(9):1857-67. PubMed ID: 15450951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.